Speakers

Expand/Collapse

David Cipolla
VP of Research
Insmed

Day One

Wednesday July 20, 2022

3:45 pm | Formulation & Delivery Challenges with Inhaled Lipid Nanoparticle Formulations

Vincent Nebot
Chief Technical Officer
Polypeptide Therapeutic Solutions (PTS)

Day One

Wednesday July 20, 2022

11:30 am | Polymer Lipid Hybrids: A Chemical Toolbox for LNP Formulations

Bryant Nelson
Staff Research Chemist
National Institute of Standards & Technology

Dr. Shan Zou
Senior Research Officer, Team Leader for Nanoscale Measurement Disciplines; Adjunct Professor of Chemistry
Metrology Research Centre of the National Research Council Canada (NRC); Carleton University

Senior Representative

Precision Nanosystems

Day One

Wednesday July 20, 2022

12:10 pm | Session Reserved for: Precision Nanosystem

Priya Karmali
Chief Technology Officer
Capstan Therapeutics

Day One

Wednesday July 20, 2022

4:45 pm | Closing Remarks & End of Day One

11:00 am | Developing Targeted Lipid Nanoparticles (tLNPs) to Enable Off-the-Shelf Immunotherapies

8:50 am | Opening Remarks

John Lewis
Founder & Chief Executive Officer
Entos Pharmaceuticals

Day Two

Thursday 21 July 2022

10:00 am | Fireside Chat

9:00 am | Exploring a Next-Gen Delivery Platform for Targeted Delivery: Fusogenix Proteo-Lipid Vehicle (PLV)

Chun-Wan Yen
Principal Scientist
Genentech

Day Two

Thursday 21 July 2022

1:15 pm | Predictive High-Throughput Screening of Oligonucleotide Lipid Nanoparticles

Cory Sago
Senior Director & Head of LNP Discovery
Beam Therapeutics

Day Two

Thursday 21 July 2022

10:00 am | Fireside Chat

9:30 am | Multiplexed Screening of LNPs in Vivo Enabled by Nucleic Acid Barcoding

Dominik Witzigmann
Co-Founder & Chief Executive Officer
Nanovation Therapeutics

Day One

Wednesday July 20, 2022

4:45 pm | Closing Remarks & End of Day One

11:40 am | Next-Generation Lipid Nanoparticle Technologies Enabling (Extra) Hepatic Nucleic Acid Delivery

8:50 am | Opening Remarks

Hemant Kumar
Chief Technology & Manufacturing Officer
Genprex

Day Two

Thursday 21 July 2022

2:15 pm | Challenges in Translating Innovative Gene Therapy Drug Targets for Accelerated Development & IND/BLA Submissions

Hila Epstein-Barash
Chief Research & Development Officer
Azura Ophthalmics

Day One

Wednesday July 20, 2022

1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver

James Ferguson
Chief Medical Officer
Matinas BioPharma

Day One

Wednesday July 20, 2022

9:30 am | Expanding Current Capabilities for Intracellular Drug Delivery with a Lipid Nano-Crystal (LNC) Platform

Day Two

Thursday 21 July 2022

10:00 am | Fireside Chat

Kalina Paunovska
Postdoctoral Scholar Dahlman Lab
Georgia Institute of Technology

Day One

Wednesday July 20, 2022

2:15 pm | Using High-Throughput LNP Screening to Identify Novel Non-Liver Delivery Vehicles

Ruchi Shah
Associate Director, New Therapeutic Modalities
Eli Lily

Day Two

Thursday 21 July 2022

11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration

Kristina Friis
Senior Scientist, Advanced Drug Delivery
AstraZeneca

Day One

Wednesday July 20, 2022

4:15 pm | Spray Drying of Lipid Nanoparticles Enables Intratracheal Delivery

Sonya Zabludoff
Vice President, Clinical Development
Nitto BioPharma

Day Two

Thursday 21 July 2022

1:45 pm | Elevating Clinical Design for a Lipid Nanoparticle Candidate

Manuel Sanchez-Felix
Senior Fellow, Novel Delivery Technologies
Novartis

Day Two

Thursday 21 July 2022

11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration

Qiaobing Xu
Founder & Chief Executive Officer
Hopewell Therapeutics

Rajesh Shinde
Senior Director of Manufacturing & Technology Operations
Genprex

Day One

Wednesday July 20, 2022

9:10 am | From Liposomes to LNPs: Evaluating the Lipid-Based Delivery Technology Landscape

Xiuling Lu
Associate Professor
University of Connecticut